Initiative expands access to affordable, shared EVs in overburdened communities while supporting New Jersey's clean transportation and emissions reduction goals. JERSEY CITY, NJ, Nov. 09, 2026 (GLOBE NEWSWIRE) --
Company Reaches Six-Month Milestone in Pivotal Trial of Fully Implanted Cochlear ImplantSecond Module of Modular PMA Application Submitted to FDA Following Quarter EndWhite Bear Lake, Minnesota--(Newsfile Corp. -
Financial Results to Be Released Before Market OpenWhite Bear Lake, Minnesota--(Newsfile Corp. - October 28, 2026) - Envoy Medical® Inc. (NASDAQ:COCH) ("Envoy Medical" or the "Company"), a hearing health
Management Will Host a Conference Call at 4:30 P.M. ET on the Same DayWhite Bear Lake, Minnesota--(Newsfile Corp. - October 27, 2026) - Envoy Medical® Inc. (NASDAQ:COCH) ("Envoy Medical" or the
White Bear Lake, Minnesota--(Newsfile Corp. - October 22, 2026) - Envoy Medical® Inc. (NASDAQ:COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully
Company Believes It Is the First to Reach This Milestone in a U.S. Pivotal Trial of a Fully Implanted Cochlear ImplantRemains on Track to Reach 12-Month Visit Milestone by Early Q2 2027 and Submit Final Clinical PMA
Second of Four Planned Modules Moves Rolling FDA Review ForwardAdvances Toward Targeted Completion of the Final Clinical Module Submission in Q2 2027White Bear Lake, Minnesota--(Newsfile Corp. - October 12, 2026) -
Canadian and Hong Kong Patents Continue to Strengthen Intellectual Property Protection Across Envoy Medical's Fully Implanted Hearing PlatformWhite Bear Lake, Minnesota--(Newsfile Corp. - September 22, 2026) - Envoy
White Bear Lake, Minnesota--(Newsfile Corp. - September 2, 2026) - Envoy Medical® Inc. (NASDAQ:COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing
Submitted First Module of Modular PMA Application to FDASubsequent to Quarter End, the Company Reported Positive 12-Month Stage 1 Data Showing Continued Improvement in Speech Perception White Bear Lake,
White Bear Lake, Minnesota--(Newsfile Corp. - July 21, 2026) - Envoy Medical® Inc. (NASDAQ:COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions,
Mean CNC word recognition scores for Stage 1 cohort improved to 53.2% at 12 months from 15.2% pre-implantation, a 38.0 percentage point gain that continued to build on the 24.0 percentage point improvement reported at 6
Modular Regulatory Strategy Creates Defined Milestone Cadence, Enables Earlier FDA Engagement, and Supports Targeted Final Clinical Module Submission Planned for Q2 2027White Bear Lake, Minnesota--(Newsfile Corp. - June
NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the June 24th & 25th Life Sciences Virtual
Termination Reflects Company's Confidence in Current Capital PositionWhite Bear Lake, Minnesota--(Newsfile Corp. - June 25, 2026) - Envoy Medical®, Inc. (NASDAQ:COCH) ("Envoy Medical"), a hearing health
